Here’s whether QIAGEN N.V. (QGEN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.05% over 10 days); RSI 63 — healthy momentum range; 3-month momentum positive (+7.7%). Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -19.2%. Currently 28.4% off its 52-week high. Score: +1/7.
QGEN is trading below its 200-day MA ($43.27) — a key warning sign the longer-term trend is under pressure. An RSI of 63.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -19.3% compares to +16.5% for SPY (trailed the market by 35.7%). The current 28.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $8,075 today
vs. S&P 500 (SPY) — same period trailed market by 35.7%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($43.27)
✓Above 50-day MA ($37.84)
✓RSI(14) neutral zone (30–70) — currently 63.1
✗Positive return (-19.3%)
!Within 10% of period high (−28.4%)
Period Range $41.37
$32.53$57.82
RSI (14) 63.1
0 · OversoldOverbought · 100
Key Metrics
Price$41.37
Period Return-19.3%
Period High$57.82
Period Low$32.53
Drawdown−28.4%
MA-50$37.84
MA-200$43.27
RSI (14)63.1
Avg Volume (30d)2.9M
vs. SPYtrailed by 35.7%
Return Rank#690 of 999
Trend Signals
Price is below the 200-day moving average ($43.27)